CHESTGuidelines & Topic CollectionsCOVID-19 Resource Center

COVID-19 Resource Center

Featured Content

  • Access key information at a glance with our infographics on post-intensive care syndrome, antimicrobial stewardship, asthma and COVID-19, and more. Clinical Resources
  • Read a comprehensive overview of the literature on aerosol drug delivery in the COVID-19 era. Guidelines, Statements, and Research
  • Watch recordings of recent webinars on coma science and sedation practices in patients with COVID-19, PTSD and moral distress in health care providers on the front lines, and lessons learned from past pandemics. Advice From the Front Lines



Clinical Resources

Find expert-vetted articles and infographics on the clinical management of COVID-19 patients, ICU administration, procedures, supply chain issues, and treatment.


Advice From the Front Lines

Watch recordings of webinars featuring CHEST experts discussing COVID-19 hot topics.


Guidelines, Statements, and Research

Access guidelines, statements, and key research related to the management of patients with COVID-19.


Voices From the Community

Hear directly from CHEST frontline physicians on their experiences navigating the pandemic.


On-Demand e-Learning

Access free e-learning modules from CHEST experts on ARDS, mechanical ventilation, hypoxemic respiratory failure, and more.


CHEST Journal

Find the latest research on the COVID-19 pandemic published in the journal CHEST®.

COVID-19 burnout

Burnout and Moral Distress Among Frontline Clinicians During the COVID-19 Pandemic

The COVID-19 pandemic has presented enormous challenges to the American health care system, and prioritizing the well-being of frontline clinicians is paramount. Even before the pandemic, nearly half of US physicians reported experiencing burnout, with pulmonologists reporting a rate of 41%.

In this special issue of Clinical Perspectives, CHEST is providing a preview of research undertaken by a team of clinicians and social scientists at the University of Minnesota to explore burnout and moral distress among health care providers in ICU and acute care settings during the COVID-19 pandemic.


Monoclonal Antibodies for Treating Patients With COVID-19

These investigational medications—approved for emergency use in patients by the FDA—may reduce progression to severe disease and shorten recovery in high-risk patients. Understand the types of monoclonal antibodies currently available in the US, indications for use, mechanisms of action, and NIH guidelines for this therapy.

Supported by Regeneron


Anti-SARS-CoV-2 Monoclonal Antibodies (mAb)

Supporter Recognition

The following companies have provided unrestricted financial support for CHEST's COVID-19 activities.

Genentech, a member of the Roche Group
Sanofi Genzyme Regeneron

Media resources

Searching for a subject matter expert to speak with you for an article or other media on COVID-19? Need vetted, reliable data for your story? Access to the journal CHEST? We can help. Please contact to speak with our team of experts.